{
    "Trade/Device Name(s)": [
        "ePlex Instrument"
    ],
    "Submitter Information": "GenMark Diagnostics, Incorporated",
    "510(k) Number": "K163652",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NSU"
    ],
    "Summary Letter Date": "May 8, 2017",
    "Summary Letter Received Date": "May 9, 2017",
    "Submission Date": "December 21, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ePlex Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex nucleic acid amplification",
        "RT-PCR",
        "PCR",
        "Competitive nucleic acid hybridization",
        "Digital microfluidics",
        "eSensor detection technology",
        "Electrowetting technology",
        "Cyclic voltammetry"
    ],
    "Methodologies": [
        "Nucleic acid extraction",
        "Amplification",
        "Hybridization",
        "Automated interpretation"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Platform",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for GenMark Diagnostics ePlex Instrument for automated multiplex nucleic acid testing using proprietary digital microfluidics and eSensor technology",
    "Indications for Use Summary": "Automated in vitro diagnostic instrument designed to perform multiplexed nucleic acid tests for simultaneous detection and identification of nucleic acid targets using single-use cartridges developed by GenMark Diagnostics",
    "fda_folder": "Clinical Chemistry"
}